MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

• click to rate

  Posted by Two Blokes Jul 11 - Filed in Stock - 5 views
  
  Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to 11 years.